advertisement

Oculus

11.4 Prostaglandins (2431)

Showing records 1 to 25

Display only abstracts from IGR 20-3 in classification 11.4 Prostaglandins

Search within classification 11.4 Prostaglandins

81819 Prospective randomized clinical trial on the effects of latanoprost, travoprost and bimatoprost on latanoprost non-responders
Blondeau P
Journal Franšais d'Ophtalmologie 2019; 42: 894-899 (IGR: 20-4)


82775 Efficacy and safety of tafluprost 0.0015% - retrospective analysis of real-world data from the Philippines
Tumbocon JA
Clinical Ophthalmology 2019; 13: 1627-1634 (IGR: 20-4)


82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Aihara M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550 (IGR: 20-4)


82758 Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost
Kumar S
Romanian journal of ophthalmology 2019; 63: 249-256 (IGR: 20-4)


82728 Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension
Sinha S
Expert Opinion in Pharmacotherapy 2020; 21: 39-45 (IGR: 20-4)


82207 Effect of topical prostaglandins on the biomechanics and shape of the cornea
Amano S
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2213-2219 (IGR: 20-4)


81875 Does using topical latanoprost affect subfoveal choroidal thickness?
Duru Z
Cutaneous and Ocular Toxicology 2019; 38: 370-374 (IGR: 20-4)


82586 Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension
Topouzis F
European Journal of Ophthalmology 2019; 0: 1120672119878044 (IGR: 20-4)


82074 Effect of Topical Prostaglandin F2α Analogs on Selected Oxidative Stress Parameters in the Tear Film
Sedlak L
Medicina (Kaunas, Lithuania) 2019; 55: (IGR: 20-4)


82048 Antiglaucoma EP Agonists: A Long Road That Led Somewhere
Woodward DF
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 469-474 (IGR: 20-4)


82350 Safety data on in situ gelling bimatoprost loaded nanovesicular formulations
Yadav M
Data in brief 2019; 25: 104361 (IGR: 20-4)


81926 Episcleral Venous Pressure and the Ocular Hypotensive Effects of Topical and Intracameral Prostaglandin Analogs
Lee SS
Journal of Glaucoma 2019; 28: 846-857 (IGR: 20-4)


82207 Effect of topical prostaglandins on the biomechanics and shape of the cornea
Nejima R
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2213-2219 (IGR: 20-4)


82586 Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension
Goldberg I
European Journal of Ophthalmology 2019; 0: 1120672119878044 (IGR: 20-4)


82074 Effect of Topical Prostaglandin F2α Analogs on Selected Oxidative Stress Parameters in the Tear Film
Zych M
Medicina (Kaunas, Lithuania) 2019; 55: (IGR: 20-4)


81926 Episcleral Venous Pressure and the Ocular Hypotensive Effects of Topical and Intracameral Prostaglandin Analogs
Robinson MR
Journal of Glaucoma 2019; 28: 846-857 (IGR: 20-4)


82775 Efficacy and safety of tafluprost 0.0015% - retrospective analysis of real-world data from the Philippines
Macasaet AM
Clinical Ophthalmology 2019; 13: 1627-1634 (IGR: 20-4)


81875 Does using topical latanoprost affect subfoveal choroidal thickness?
Özsaygılı C
Cutaneous and Ocular Toxicology 2019; 38: 370-374 (IGR: 20-4)


82048 Antiglaucoma EP Agonists: A Long Road That Led Somewhere
Wang JW
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 469-474 (IGR: 20-4)


82350 Safety data on in situ gelling bimatoprost loaded nanovesicular formulations
Guzman-Aranguez A
Data in brief 2019; 25: 104361 (IGR: 20-4)


81819 Prospective randomized clinical trial on the effects of latanoprost, travoprost and bimatoprost on latanoprost non-responders
Hamid M
Journal Franšais d'Ophtalmologie 2019; 42: 894-899 (IGR: 20-4)


82728 Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension
Lee D
Expert Opinion in Pharmacotherapy 2020; 21: 39-45 (IGR: 20-4)


82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Lu F
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550 (IGR: 20-4)


82758 Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost
Singh T
Romanian journal of ophthalmology 2019; 63: 249-256 (IGR: 20-4)


82728 Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension
Kolomeyer NN
Expert Opinion in Pharmacotherapy 2020; 21: 39-45 (IGR: 20-4)



Issue 20-3

Select Issue


advertisement

WGW-2021